It was a month stuffed with several different kinds of wins for the pharmaceutical company.Any pharmaceutical company as large and sprawling as AbbVie (ABBV 1.41%) never stops being busy, from pushing investigational drugs along the development pipeline to shipping blockbuster medications to pharmacies.As in any month, September was eventful for AbbVie. In addition to news about its usual activities, it also scored big with investors because of an important settlement it reached on a key product. Ultimately ...